1
|
Farrell J, Docherty AB, Thorpe MG, Shaw CA, Harrison EM, Lone NI. Twelve-month risk of thromboembolic events in COVID-19 hospital survivors in Scotland. Anaesthesia 2022; 77:1445-1447. [PMID: 36000949 PMCID: PMC9538279 DOI: 10.1111/anae.15826] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 07/18/2022] [Indexed: 11/30/2022]
Affiliation(s)
- J Farrell
- University of Edinburgh, Edinburgh, UK
| | | | | | - C A Shaw
- University of Edinburgh, Edinburgh, UK
| | | | - N I Lone
- University of Edinburgh, Edinburgh, UK
| |
Collapse
|
2
|
Bairwa SC, Shaw CA, Kuo M, Yoo J, Tomljenovic L, Eidi H. Cytokines profile in neonatal and adult wild-type mice post-injection of U. S. pediatric vaccination schedule. Brain Behav Immun Health 2021; 15:100267. [PMID: 34589773 PMCID: PMC8474652 DOI: 10.1016/j.bbih.2021.100267] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/08/2021] [Revised: 05/02/2021] [Accepted: 05/03/2021] [Indexed: 11/09/2022] Open
Abstract
Introduction A recent study from our laboratory demonstrated a number of neurobehavioral abnormalities in mice colony injected with a mouse-weight equivalent dose of all vaccines that are administered to infants in their first 18 months of life according to the U. S. pediatric vaccination schedule. Cytokines have been studied extensively as blood immune and inflammatory biomarkers, and their association with neurodevelopmental disorders. Given the importance of cytokines in early neurodevelopment, we aimed to investigate the potential post-administration effects of the U. S. pediatric vaccines on circulatory cytokines in a mouse model. In the current study, cytokines have been assayed at early and late time points in mice vaccinated early in postnatal life and compared with placebo controls. Materials and methods Newborn mouse pups were divided into three groups: i) vaccine (V1), ii) vaccine × 3 (V3) and iii) placebo control. V1 group was injected with mouse weight-equivalent of the current U. S. pediatric vaccine schedule. V3 group was injected with same vaccines but at triple the dose and the placebo control was injected with saline. Pups were also divided according to the sampling age into two main groups: acute- and chronic-phase group. Blood samples were collected at postnatal day (PND) 23, two days following vaccine schedule for the acute-phase group or at 67 weeks post-vaccination for the chronic-phase groups. Fifteen cytokines were analyzed: GM-CSF, IFN-γ, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-9, IL-10, IL-12p70, IL-13, IL-17A, MCP-1, TNF-α, and VEGF-A. Wilcoxon Rank Sum test or unpaired Student's t-test was performed where applicable. Results IL-5 levels in plasma were significantly elevated in the V1 and V3 group compared with the control only in the acute-phase group. The elevation of IL-5 levels in the two vaccine groups were significant irrespective of whether the sexes were combined or analyzed separately. Other cytokines (VEGF-A, TNF-α, IL-10, MCP-1, GM-CSF, IL-6, and IL-13) were also impacted, although to a lesser extent and in a sex-dependent manner. In the acute-phase group, females showed a significant increase in IL-10 and MCP-1 levels and a decrease in VEGF-A levels in both V1 and V3 group compared to controls. In the acute-phase, a significant increase in MCP-1 levels in V3 group and CM-CSF levels in V1 and V3 group and decrease in TNF-α levels in V1 group were observed in treated males as compared with controls. In chronic-phase females, levels of VEGF-A in V1 and V3 group, TNF-α in V3 group, and IL-13 in V1 group were significantly decreased in contrast with controls. In chronic-phase males, TNF-α levels were significantly increased in V1 group and IL-6 levels decreased in V3 group in comparison to controls. The changes in levels of most tested cytokines were altered between the early and the late postnatal assays. Conclusions IL-5 levels significantly increased in the acute-phase of the treatment in the plasma of both sexes that were subjected to V1 and V3 injections. These increases had diminished by the second test assayed at week 67. These results suggest that a profound, albeit transient, effect on cytokine levels may be induced by the whole vaccine administration supporting our recently published observations regarding the behavioral abnormalities in the same mice. These observations support the view that the administration of whole pediatric vaccines in a neonatal period may impact at least short-term CNS functions in mice.
Collapse
Affiliation(s)
- S C Bairwa
- Department of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver, British Columbia, Canada
| | - C A Shaw
- Department of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver, British Columbia, Canada.,Department of Pathology, University of British Columbia, Vancouver, British Columbia, Canada.,Program in Neuroscience, University of British Columbia, Vancouver, British Columbia, Canada.,Program in Experimental Medicine, University of British Columbia, Vancouver, British Columbia, Canada
| | - M Kuo
- Department of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver, British Columbia, Canada
| | - J Yoo
- Department of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver, British Columbia, Canada
| | - L Tomljenovic
- Department of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver, British Columbia, Canada
| | - H Eidi
- Department of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver, British Columbia, Canada.,French Agency for Veterinary Medicinal Products (ANMV) - French Agency for Food, Environmental and Occupational Health Safety (ANSES), Fougères, France
| |
Collapse
|
3
|
McLean KA, Mountain KE, Shaw CA, Drake TM, Ots R, Knight SR, Fairfield CJ, Sgrò A, Skipworth RJE, Wigmore SJ, Potter MA, Harrison EM. O8 Tracking wound infection with smartphone technology (twist): a randomised controlled trial in emergency surgery patients. Br J Surg 2021. [DOI: 10.1093/bjs/znab282.013] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
Abstract
Abstract
Introduction
Surgical site infections (SSI) complicate 2%–10% of general surgery cases, and represent a significant burden on acute healthcare services. We aim to investigate if a smartphone-delivered wound assessment tool results in earlier treatment.
Method
This parallel, single-blinded randomised control trial enrolled adult emergency abdominal surgery patients in two tertiary hospitals (ClinicalTrials.gov number, NCT02704897). Patients were randomised (1:1 ratio) between standard postoperative care and additional access to a smartphone-delivered wound assessment tool for 30-days postoperatively. Patients routinely submitted wound questionnaires and photos for surgical review at postoperative days 3, 7, and 15. The primary outcome measure was time-to-diagnosis of SSI (CDC definition) within 30 postoperative days.
Result
492 patients undergoing emergency surgery were randomised (smartphone intervention = 223; standard care = 269). There was no significant difference (P = 0.513) in the 30-day SSI rate between trial arms: 21 (9.4%) in smartphone vs 20 (7.4%) in standard care. While the mean time-to-diagnosis of SSI was 9.3 days (SD = 6.3) in the smartphone group, and 11.8 days (SD = 6.7) in the control group, this did not demonstrate a significant difference for the primary outcome (P = 0.255). However, patients in the smartphone group had 3.7-fold higher odds to be diagnosed in first 7 postoperative days (95% CI: 1.02 to 13.51, P = 0.043).
Conclusion
Digital patient-driven postoperative wound follow-up can be feasibly delivered in a broad cohort of emergency surgery patients. This can facilitate triage of patients to the appropriate level of assessment required, allowing diagnosis of SSI earlier in the postoperative period.
Take-home Message
Digital patient-driven postoperative wound follow-up can be feasibly delivered in a broad cohort of emergency surgery patients. This can facilitate triage of patients to the appropriate level of assessment required, allowing diagnosis of SSI earlier in the postoperative period.
Collapse
Affiliation(s)
- K A McLean
- Department of Clinical Surgery, University of Edinburgh, Edinburgh, UK
| | - K E Mountain
- Department of Clinical Surgery, University of Edinburgh, Edinburgh, UK
| | - C A Shaw
- Department of Clinical Surgery, University of Edinburgh, Edinburgh, UK
| | - T M Drake
- Department of Clinical Surgery, University of Edinburgh, Edinburgh, UK
| | - Riinu Ots
- Department of Clinical Surgery, University of Edinburgh, Edinburgh, UK
| | - Stephen R Knight
- Department of Clinical Surgery, University of Edinburgh, Edinburgh, UK
| | | | - Alessandro Sgrò
- Department of Clinical Surgery, University of Edinburgh, Edinburgh, UK
| | | | - Stephen J Wigmore
- Department of Clinical Surgery, University of Edinburgh, Edinburgh, UK
| | - Mark A Potter
- Department of Colorectal Surgery, Western General Hospital, Edinburgh, UK
| | - Ewen M Harrison
- Department of Clinical Surgery, University of Edinburgh, Edinburgh, UK
| | | |
Collapse
|
4
|
Shaw CA, Kole LCS, Elewski BE. Association of psoriasis/psoriatic arthritis with inflammatory bowel disease influences management strategy. J Eur Acad Dermatol Venereol 2019; 33:e431-e432. [PMID: 31220373 DOI: 10.1111/jdv.15752] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Affiliation(s)
- C A Shaw
- Department of Dermatology, University of Alabama at Birmingham, Birmingham, AL, USA
| | - L C S Kole
- Department of Dermatology, University of Alabama at Birmingham, Birmingham, AL, USA
| | - B E Elewski
- Department of Dermatology, University of Alabama at Birmingham, Birmingham, AL, USA
| |
Collapse
|
5
|
Bayer DK, Martinez CA, Sorte HS, Forbes LR, Demmler-Harrison GJ, Hanson IC, Pearson NM, Noroski LM, Zaki SR, Bellini WJ, Leduc MS, Yang Y, Eng CM, Patel A, Rodningen OK, Muzny DM, Gibbs RA, Campbell IM, Shaw CA, Baker MW, Zhang V, Lupski JR, Orange JS, Seeborg FO, Stray-Pedersen A. Vaccine-associated varicella and rubella infections in severe combined immunodeficiency with isolated CD4 lymphocytopenia and mutations in IL7R detected by tandem whole exome sequencing and chromosomal microarray. Clin Exp Immunol 2014; 178:459-69. [PMID: 25046553 PMCID: PMC4238873 DOI: 10.1111/cei.12421] [Citation(s) in RCA: 45] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 07/16/2014] [Indexed: 12/22/2022] Open
Abstract
In areas without newborn screening for severe combined immunodeficiency (SCID), disease-defining infections may lead to diagnosis, and in some cases, may not be identified prior to the first year of life. We describe a female infant who presented with disseminated vaccine-acquired varicella (VZV) and vaccine-acquired rubella infections at 13 months of age. Immunological evaluations demonstrated neutropenia, isolated CD4 lymphocytopenia, the presence of CD8(+) T cells, poor lymphocyte proliferation, hypergammaglobulinaemia and poor specific antibody production to VZV infection and routine immunizations. A combination of whole exome sequencing and custom-designed chromosomal microarray with exon coverage of primary immunodeficiency genes detected compound heterozygous mutations (one single nucleotide variant and one intragenic copy number variant involving one exon) within the IL7R gene. Mosaicism for wild-type allele (20-30%) was detected in pretransplant blood and buccal DNA and maternal engraftment (5-10%) demonstrated in pretransplant blood DNA. This may be responsible for the patient's unusual immunological phenotype compared to classical interleukin (IL)-7Rα deficiency. Disseminated VZV was controlled with anti-viral and immune-based therapy, and umbilical cord blood stem cell transplantation was successful. Retrospectively performed T cell receptor excision circle (TREC) analyses completed on neonatal Guthrie cards identified absent TREC. This case emphasizes the danger of live viral vaccination in severe combined immunodeficiency (SCID) patients and the importance of newborn screening to identify patients prior to high-risk exposures. It also illustrates the value of aggressive pathogen identification and treatment, the influence newborn screening can have on morbidity and mortality and the significant impact of newer genomic diagnostic tools in identifying the underlying genetic aetiology for SCID patients.
Collapse
Affiliation(s)
- D K Bayer
- Department of Pediatrics, Section of Immunology, Allergy, and Rheumatology, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
6
|
Li Y, Shaw CA, Sheffer I, Sule N, Powell SZ, Dawson B, Zaidi SNY, Bucasas KL, Lupski JR, Wilhelmsen KC, Doody R, Szigeti K. Integrated copy number and gene expression analysis detects a CREB1 association with Alzheimer's disease. Transl Psychiatry 2012; 2:e192. [PMID: 23168992 PMCID: PMC3565761 DOI: 10.1038/tp.2012.119] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
Abstract
Genetic variation, both single-nucleotide variations and copy number variations (CNV), contribute to changes in gene expression. In some cases these variations are meaningfully correlated with disease states. We hypothesized that in a genetically heterogeneous disorder such as sporadic Alzheimer's disease (AD), utilizing gene expression as a quantitative trait and CNVs as a genetic marker map within the same individuals in the context of case-control status may increase the power to detect relevant loci. Using this approach an 8-kb deletion was identified that contains a PAX6-binding site on chr2q33.3 upstream of CREB1 encoding the cAMP responsive element-binding protein1 transcription factor. The association of the CNV to AD was confirmed by a case-control association study consisting of the Texas Alzheimer Research and Care Consortium and NIA-LOAD Family Study data sets.
Collapse
Affiliation(s)
- Y Li
- Department of Neurology, Alzheimer's Disease and Memory Disorders Center, Baylor College of Medicine, Houston, TX, USA
| | - C A Shaw
- Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA,Department of Molecular and Human Genetics, Baylor College of Medicine, 1 Baylor Plaza, Houston, TX, USA. E-mail:
| | - I Sheffer
- Department of Neurology, Alzheimer's Disease and Memory Disorders Center, Baylor College of Medicine, Houston, TX, USA
| | - N Sule
- Department of Pathology, Baylor College of Medicine, Houston, TX, USA
| | - S Z Powell
- Department of Neuropathology, The Methodist Hospital, Houston, TX, USA
| | - B Dawson
- Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA,Howard Hughes Medical Institute, Houston, TX, USA
| | - S N Y Zaidi
- Department of Neurology, Alzheimer's Disease and Memory Disorders Center, Baylor College of Medicine, Houston, TX, USA
| | - K L Bucasas
- Departmentof Immunology, Baylor College of Medicine, Houston, TX, USA
| | - J R Lupski
- Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA,Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA
| | - K C Wilhelmsen
- Department of Neurology, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
| | - R Doody
- Department of Neurology, Alzheimer's Disease and Memory Disorders Center, Baylor College of Medicine, Houston, TX, USA
| | - K Szigeti
- Department of Neurology, Alzheimer's Disease and Memory Disorders Center, Baylor College of Medicine, Houston, TX, USA,Department of Neurology, University at Buffalo, SUNY, Buffalo, NY, USA,Department of Neurology, University of Buffalo, SUNY, 100 High Street, Buffalo, NY 14203, USA. E-mail:
| |
Collapse
|
7
|
|
8
|
Abstract
Immune challenges during early development, including those vaccine-induced, can lead to permanent detrimental alterations of the brain and immune function. Experimental evidence also shows that simultaneous administration of as little as two to three immune adjuvants can overcome genetic resistance to autoimmunity. In some developed countries, by the time children are 4 to 6 years old, they will have received a total of 126 antigenic compounds along with high amounts of aluminum (Al) adjuvants through routine vaccinations. According to the US Food and Drug Administration, safety assessments for vaccines have often not included appropriate toxicity studies because vaccines have not been viewed as inherently toxic. Taken together, these observations raise plausible concerns about the overall safety of current childhood vaccination programs. When assessing adjuvant toxicity in children, several key points ought to be considered: (i) infants and children should not be viewed as “small adults” with regard to toxicological risk as their unique physiology makes them much more vulnerable to toxic insults; (ii) in adult humans Al vaccine adjuvants have been linked to a variety of serious autoimmune and inflammatory conditions (i.e., “ASIA”), yet children are regularly exposed to much higher amounts of Al from vaccines than adults; (iii) it is often assumed that peripheral immune responses do not affect brain function. However, it is now clearly established that there is a bidirectional neuro-immune cross-talk that plays crucial roles in immunoregulation as well as brain function. In turn, perturbations of the neuro-immune axis have been demonstrated in many autoimmune diseases encompassed in “ASIA” and are thought to be driven by a hyperactive immune response; and (iv) the same components of the neuro-immune axis that play key roles in brain development and immune function are heavily targeted by Al adjuvants. In summary, research evidence shows that increasing concerns about current vaccination practices may indeed be warranted. Because children may be most at risk of vaccine-induced complications, a rigorous evaluation of the vaccine-related adverse health impacts in the pediatric population is urgently needed.
Collapse
Affiliation(s)
- L Tomljenovic
- Neural Dynamics Research Group, Department of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver, BC, Canada
| | - CA Shaw
- Departments of Ophthalmology and Visual Sciences and Experimental Medicine and the Graduate Program in Neuroscience, University of British Columbia, Vancouver, BC, Canada
| |
Collapse
|
9
|
Abstract
Aluminum is an experimentally demonstrated neurotoxin and the most commonly used vaccine adjuvant. Despite almost 90 years of widespread use of aluminum adjuvants, medical science's understanding about their mechanisms of action is still remarkably poor. There is also a concerning scarcity of data on toxicology and pharmacokinetics of these compounds. In spite of this, the notion that aluminum in vaccines is safe appears to be widely accepted. Experimental research, however, clearly shows that aluminum adjuvants have a potential to induce serious immunological disorders in humans. In particular, aluminum in adjuvant form carries a risk for autoimmunity, long-term brain inflammation and associated neurological complications and may thus have profound and widespread adverse health consequences. In our opinion, the possibility that vaccine benefits may have been overrated and the risk of potential adverse effects underestimated, has not been rigorously evaluated in the medical and scientific community. We hope that the present paper will provide a framework for a much needed and long overdue assessment of this highly contentious medical issue.
Collapse
Affiliation(s)
- L Tomljenovic
- Neural Dynamics Research Group, Department of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver, BC, V5Z 1L8, Canada.
| | | |
Collapse
|
10
|
Shaw CA, Li Y, Wiszniewska J, Chasse S, Zaidi SNY, Jin W, Dawson B, Wilhelmsen K, Lupski JR, Belmont JW, Doody RS, Szigeti K. Olfactory copy number association with age at onset of Alzheimer disease. Neurology 2011; 76:1302-9. [PMID: 21482944 DOI: 10.1212/wnl.0b013e3182166df5] [Citation(s) in RCA: 32] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022] Open
Abstract
OBJECTIVES Copy number variants (CNVs) have been recognized as a source of genetic variation that contributes to disease phenotypes. Alzheimer disease (AD) has high heritability for occurrence and age at onset (AAO). We performed a cases-only genome-wide CNV association study for age at onset of AD. METHODS The discovery case series (n = 40 subjects with AD) was evaluated using array comparative genome hybridization (aCGH). A replication case series (n = 507 subjects with AD) was evaluated using Affymetrix array (n = 243) and multiplex ligation-dependent probe amplification (n = 264). Hazard models related onset age to CNV. RESULTS The discovery sample identified a chromosomal segment on 14q11.2 (19.3-19.5 Mb, NCBI build 36, UCSC hg18 March 2006) as a region of interest (genome-wide adjusted p = 0.032) for association with AAO of AD. This region encompasses a cluster of olfactory receptors. The replication sample confirmed the association (p = 0.035). The association was found for each APOE4 gene dosage (0, 1, and 2). CONCLUSION High copy number in the olfactory receptor region on 14q11.2 is associated with younger age at onset of AD.
Collapse
Affiliation(s)
- C A Shaw
- Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
11
|
Sun T, Meerbrey KL, Kessler J, Botero M, Migliaccio I, Nguyen DX, Pavlova NN, Bernardi RJ, Schmitt E, Hilsenbeck SG, Creighton CJ, Shaw CA, Gibbs R, Wheeler D, Osborne CK, Schiff R, Elledge SJ, Westbrook TF. Abstract S6-10: Identification of a Novel Tumor Suppressor Network Reveals a Role for Proto-Oncogenic Receptor Tyrosine Kinases in Triple-Negative Breast Cancer. Cancer Res 2010. [DOI: 10.1158/0008-5472.sabcs10-s6-10] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Breast cancer is a collection of diseases with distinct clinical behaviors and underlying genetic causes. Triple-negative breast cancer (TNBC) is a common subtype of breast cancer that confers a particularly poor prognosis and is refractory to current targeted therapies. Unfortunately, the molecular determinants driving this aggressive malignancy are poorly understood. Using an unbiased genetic screen, we have identified a novel tumor suppressor network that governs proliferation and transformation of TNBCs in vitro and in vivo. We define SECT21 as a core component in this network and a commonly inactivated tumor suppressor in TNBC. SECT21 is a potent suppressor of human mammary epithelial cell proliferation and transformation. SECT21 function is frequently compromised in human TNBCs by inactivating mutations, deletion, or loss of protein expression. Mechanistically, SECT21 is a tyrosine phosphatase that suppresses cellular transformation by interacting with and inhibiting several oncogenic receptor tyrosine kinases including HER2, EGFR, and PDGFR. Notably, the tumorigenic and metastatic potential of SECT21-deficient TNBCs is severely impaired by restoring SECT21 function or by inhibiting kinase targets of SECT21, suggesting that TNBCs are dependent on the proto-oncogenic tyrosine kinases constrained by SECT21. Collectively, these data identify SECT21 as a commonly inactivated tumor suppressor and provide a rationale for combinatorially targeting tyrosine kinases in TNBC and other cancers based on their profile of tyrosine phosphatase activity.
Citation Information: Cancer Res 2010;70(24 Suppl):Abstract nr S6-10.
Collapse
Affiliation(s)
- T Sun
- Verna & Marrs McLean Dept. of Biochemistry & Molecular Biology, Baylor College of Medicine, Houston, TX; Dept. of Molecular & Human Genetics, Baylor College of Medicine, Houston, TX; Dept. of Pediatrics, Baylor College of Medicine, Houston, TX; Dan L. Duncan Cancer Center Division of Biostatistics, Baylor College of Medicine, Houston, TX; The Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, TX; The Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX; Dept. of Pathology, Yale University School of Medicine, New Haven, CT; Howard Hughes Medical Institute and Dept. of Genetics, Brigham & Women's Hospital, Harvard Medical School, Boston, MA
| | - KL Meerbrey
- Verna & Marrs McLean Dept. of Biochemistry & Molecular Biology, Baylor College of Medicine, Houston, TX; Dept. of Molecular & Human Genetics, Baylor College of Medicine, Houston, TX; Dept. of Pediatrics, Baylor College of Medicine, Houston, TX; Dan L. Duncan Cancer Center Division of Biostatistics, Baylor College of Medicine, Houston, TX; The Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, TX; The Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX; Dept. of Pathology, Yale University School of Medicine, New Haven, CT; Howard Hughes Medical Institute and Dept. of Genetics, Brigham & Women's Hospital, Harvard Medical School, Boston, MA
| | - J Kessler
- Verna & Marrs McLean Dept. of Biochemistry & Molecular Biology, Baylor College of Medicine, Houston, TX; Dept. of Molecular & Human Genetics, Baylor College of Medicine, Houston, TX; Dept. of Pediatrics, Baylor College of Medicine, Houston, TX; Dan L. Duncan Cancer Center Division of Biostatistics, Baylor College of Medicine, Houston, TX; The Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, TX; The Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX; Dept. of Pathology, Yale University School of Medicine, New Haven, CT; Howard Hughes Medical Institute and Dept. of Genetics, Brigham & Women's Hospital, Harvard Medical School, Boston, MA
| | - M Botero
- Verna & Marrs McLean Dept. of Biochemistry & Molecular Biology, Baylor College of Medicine, Houston, TX; Dept. of Molecular & Human Genetics, Baylor College of Medicine, Houston, TX; Dept. of Pediatrics, Baylor College of Medicine, Houston, TX; Dan L. Duncan Cancer Center Division of Biostatistics, Baylor College of Medicine, Houston, TX; The Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, TX; The Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX; Dept. of Pathology, Yale University School of Medicine, New Haven, CT; Howard Hughes Medical Institute and Dept. of Genetics, Brigham & Women's Hospital, Harvard Medical School, Boston, MA
| | - I Migliaccio
- Verna & Marrs McLean Dept. of Biochemistry & Molecular Biology, Baylor College of Medicine, Houston, TX; Dept. of Molecular & Human Genetics, Baylor College of Medicine, Houston, TX; Dept. of Pediatrics, Baylor College of Medicine, Houston, TX; Dan L. Duncan Cancer Center Division of Biostatistics, Baylor College of Medicine, Houston, TX; The Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, TX; The Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX; Dept. of Pathology, Yale University School of Medicine, New Haven, CT; Howard Hughes Medical Institute and Dept. of Genetics, Brigham & Women's Hospital, Harvard Medical School, Boston, MA
| | - DX Nguyen
- Verna & Marrs McLean Dept. of Biochemistry & Molecular Biology, Baylor College of Medicine, Houston, TX; Dept. of Molecular & Human Genetics, Baylor College of Medicine, Houston, TX; Dept. of Pediatrics, Baylor College of Medicine, Houston, TX; Dan L. Duncan Cancer Center Division of Biostatistics, Baylor College of Medicine, Houston, TX; The Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, TX; The Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX; Dept. of Pathology, Yale University School of Medicine, New Haven, CT; Howard Hughes Medical Institute and Dept. of Genetics, Brigham & Women's Hospital, Harvard Medical School, Boston, MA
| | - NN Pavlova
- Verna & Marrs McLean Dept. of Biochemistry & Molecular Biology, Baylor College of Medicine, Houston, TX; Dept. of Molecular & Human Genetics, Baylor College of Medicine, Houston, TX; Dept. of Pediatrics, Baylor College of Medicine, Houston, TX; Dan L. Duncan Cancer Center Division of Biostatistics, Baylor College of Medicine, Houston, TX; The Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, TX; The Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX; Dept. of Pathology, Yale University School of Medicine, New Haven, CT; Howard Hughes Medical Institute and Dept. of Genetics, Brigham & Women's Hospital, Harvard Medical School, Boston, MA
| | - RJ Bernardi
- Verna & Marrs McLean Dept. of Biochemistry & Molecular Biology, Baylor College of Medicine, Houston, TX; Dept. of Molecular & Human Genetics, Baylor College of Medicine, Houston, TX; Dept. of Pediatrics, Baylor College of Medicine, Houston, TX; Dan L. Duncan Cancer Center Division of Biostatistics, Baylor College of Medicine, Houston, TX; The Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, TX; The Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX; Dept. of Pathology, Yale University School of Medicine, New Haven, CT; Howard Hughes Medical Institute and Dept. of Genetics, Brigham & Women's Hospital, Harvard Medical School, Boston, MA
| | - E Schmitt
- Verna & Marrs McLean Dept. of Biochemistry & Molecular Biology, Baylor College of Medicine, Houston, TX; Dept. of Molecular & Human Genetics, Baylor College of Medicine, Houston, TX; Dept. of Pediatrics, Baylor College of Medicine, Houston, TX; Dan L. Duncan Cancer Center Division of Biostatistics, Baylor College of Medicine, Houston, TX; The Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, TX; The Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX; Dept. of Pathology, Yale University School of Medicine, New Haven, CT; Howard Hughes Medical Institute and Dept. of Genetics, Brigham & Women's Hospital, Harvard Medical School, Boston, MA
| | - SG Hilsenbeck
- Verna & Marrs McLean Dept. of Biochemistry & Molecular Biology, Baylor College of Medicine, Houston, TX; Dept. of Molecular & Human Genetics, Baylor College of Medicine, Houston, TX; Dept. of Pediatrics, Baylor College of Medicine, Houston, TX; Dan L. Duncan Cancer Center Division of Biostatistics, Baylor College of Medicine, Houston, TX; The Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, TX; The Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX; Dept. of Pathology, Yale University School of Medicine, New Haven, CT; Howard Hughes Medical Institute and Dept. of Genetics, Brigham & Women's Hospital, Harvard Medical School, Boston, MA
| | - CJ Creighton
- Verna & Marrs McLean Dept. of Biochemistry & Molecular Biology, Baylor College of Medicine, Houston, TX; Dept. of Molecular & Human Genetics, Baylor College of Medicine, Houston, TX; Dept. of Pediatrics, Baylor College of Medicine, Houston, TX; Dan L. Duncan Cancer Center Division of Biostatistics, Baylor College of Medicine, Houston, TX; The Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, TX; The Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX; Dept. of Pathology, Yale University School of Medicine, New Haven, CT; Howard Hughes Medical Institute and Dept. of Genetics, Brigham & Women's Hospital, Harvard Medical School, Boston, MA
| | - CA Shaw
- Verna & Marrs McLean Dept. of Biochemistry & Molecular Biology, Baylor College of Medicine, Houston, TX; Dept. of Molecular & Human Genetics, Baylor College of Medicine, Houston, TX; Dept. of Pediatrics, Baylor College of Medicine, Houston, TX; Dan L. Duncan Cancer Center Division of Biostatistics, Baylor College of Medicine, Houston, TX; The Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, TX; The Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX; Dept. of Pathology, Yale University School of Medicine, New Haven, CT; Howard Hughes Medical Institute and Dept. of Genetics, Brigham & Women's Hospital, Harvard Medical School, Boston, MA
| | - R Gibbs
- Verna & Marrs McLean Dept. of Biochemistry & Molecular Biology, Baylor College of Medicine, Houston, TX; Dept. of Molecular & Human Genetics, Baylor College of Medicine, Houston, TX; Dept. of Pediatrics, Baylor College of Medicine, Houston, TX; Dan L. Duncan Cancer Center Division of Biostatistics, Baylor College of Medicine, Houston, TX; The Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, TX; The Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX; Dept. of Pathology, Yale University School of Medicine, New Haven, CT; Howard Hughes Medical Institute and Dept. of Genetics, Brigham & Women's Hospital, Harvard Medical School, Boston, MA
| | - D Wheeler
- Verna & Marrs McLean Dept. of Biochemistry & Molecular Biology, Baylor College of Medicine, Houston, TX; Dept. of Molecular & Human Genetics, Baylor College of Medicine, Houston, TX; Dept. of Pediatrics, Baylor College of Medicine, Houston, TX; Dan L. Duncan Cancer Center Division of Biostatistics, Baylor College of Medicine, Houston, TX; The Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, TX; The Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX; Dept. of Pathology, Yale University School of Medicine, New Haven, CT; Howard Hughes Medical Institute and Dept. of Genetics, Brigham & Women's Hospital, Harvard Medical School, Boston, MA
| | - CK Osborne
- Verna & Marrs McLean Dept. of Biochemistry & Molecular Biology, Baylor College of Medicine, Houston, TX; Dept. of Molecular & Human Genetics, Baylor College of Medicine, Houston, TX; Dept. of Pediatrics, Baylor College of Medicine, Houston, TX; Dan L. Duncan Cancer Center Division of Biostatistics, Baylor College of Medicine, Houston, TX; The Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, TX; The Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX; Dept. of Pathology, Yale University School of Medicine, New Haven, CT; Howard Hughes Medical Institute and Dept. of Genetics, Brigham & Women's Hospital, Harvard Medical School, Boston, MA
| | - R Schiff
- Verna & Marrs McLean Dept. of Biochemistry & Molecular Biology, Baylor College of Medicine, Houston, TX; Dept. of Molecular & Human Genetics, Baylor College of Medicine, Houston, TX; Dept. of Pediatrics, Baylor College of Medicine, Houston, TX; Dan L. Duncan Cancer Center Division of Biostatistics, Baylor College of Medicine, Houston, TX; The Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, TX; The Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX; Dept. of Pathology, Yale University School of Medicine, New Haven, CT; Howard Hughes Medical Institute and Dept. of Genetics, Brigham & Women's Hospital, Harvard Medical School, Boston, MA
| | - SJ Elledge
- Verna & Marrs McLean Dept. of Biochemistry & Molecular Biology, Baylor College of Medicine, Houston, TX; Dept. of Molecular & Human Genetics, Baylor College of Medicine, Houston, TX; Dept. of Pediatrics, Baylor College of Medicine, Houston, TX; Dan L. Duncan Cancer Center Division of Biostatistics, Baylor College of Medicine, Houston, TX; The Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, TX; The Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX; Dept. of Pathology, Yale University School of Medicine, New Haven, CT; Howard Hughes Medical Institute and Dept. of Genetics, Brigham & Women's Hospital, Harvard Medical School, Boston, MA
| | - TF. Westbrook
- Verna & Marrs McLean Dept. of Biochemistry & Molecular Biology, Baylor College of Medicine, Houston, TX; Dept. of Molecular & Human Genetics, Baylor College of Medicine, Houston, TX; Dept. of Pediatrics, Baylor College of Medicine, Houston, TX; Dan L. Duncan Cancer Center Division of Biostatistics, Baylor College of Medicine, Houston, TX; The Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, TX; The Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX; Dept. of Pathology, Yale University School of Medicine, New Haven, CT; Howard Hughes Medical Institute and Dept. of Genetics, Brigham & Women's Hospital, Harvard Medical School, Boston, MA
| |
Collapse
|
12
|
Miller MR, McLean SG, Duffin R, Shaw CA, Mills NL, Donaldson K, Newby DE, Hadoke PWF. BAS/BSCR27 Diesel exhaust particles promote atherosclerosis in apolipoprotein E-deficient mice. Heart 2010. [DOI: 10.1136/hrt.2010.205781.38] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
13
|
Abstract
A right metacarpal III represents the first North American record of the giant anteater (Myrmecophaga tridactyla). Recovered in northwestern Sonora, Mexico, with a rich vertebrate fauna of early Pleistocene (Irvingtonian) age, it belongs to a cohort of large mammals that dispersed from South America to North America along a savanna corridor. Presumably habitat and climatic changes have subsequently driven this mammalian family more than 3000 kilometers back into Central America from its former expansion into temperate North America.
Collapse
|
14
|
Richards JMJ, Shaw CA, Lang NN, Semple SI, Crawford JH, Mills NL, Dhaliwal K, Simpson AJ, Burdess A, Roddie H, McKillop G, Atkinson AP, Forrest E, Connolly TM, Feuerstein GZ, Barclay GR, Turner ML, Newby DE. 074 In vivo cell tracking of superparamagnetic iron oxide-labelled mononuclear cells in humans. Heart 2010. [DOI: 10.1136/hrt.2010.195966.22] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
15
|
Affiliation(s)
- L R Snyder
- Department of Chemistry, Box 351700, University of Washington, Seattle, WA 98195-1700, USA.
| | | | | | | | | | | |
Collapse
|
16
|
Ben-Shachar S, Khajavi M, Withers MA, Shaw CA, van Bokhoven H, Brunner HG, Lupski JR. Dominant versus recessive traits conveyed by allelic mutations - to what extent is nonsense-mediated decay involved? Clin Genet 2009; 75:394-400. [PMID: 19236432 DOI: 10.1111/j.1399-0004.2008.01114.x] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Abstract
Mutations in ROR2, encoding a receptor tyrosine kinase, can cause autosomal recessive Robinow syndrome (RRS), a severe skeletal dysplasia with limb shortening, brachydactyly, and a dysmorphic facial appearance. Other mutations in ROR2 result in the autosomal dominant disease, brachydactyly type B (BDB1). No functional mechanisms have been delineated to effectively explain the association between mutations and different modes of inheritance causing different phenotypes. BDB1-causing mutations in ROR2 result from heterozygous premature termination codons (PTCs) in downstream exons and the conveyed phenotype segregates as an autosomal dominant trait, whereas heterozygous missense mutations and PTCs in upstream exons result in carrier status for RRS. Given that the distribution of PTC mutations revealed a correlation between the phenotype and the mode of inheritance conveyed, we investigated the potential role for the nonsense-mediated decay (NMD) pathway in the abrogation of possible aberrant effects of selected mutant alleles. Our experiments show that triggering or escaping NMD may cause different phenotypes with a distinct mode of inheritance. We generalize these findings to other disease-associated genes by examining PTC mutation distribution correlation with conveyed phenotype and inheritance patterns. Indeed, NMD may explain distinct phenotypes and different inheritance patterns conveyed by allelic truncating mutations enabling better genotype-phenotype correlations in several other disorders.
Collapse
Affiliation(s)
- S Ben-Shachar
- Department of Molecular and Human Genetic, Baylor College of Medicine, Houston, TX 77030, USA
| | | | | | | | | | | | | |
Collapse
|
17
|
Duffin R, Shaw CA, Rossi AG. Sildenafil reduces the alcohol-induced gastric damage: just say ‘NO’. Br J Pharmacol 2008. [DOI: 10.1038/bjp.2008.103] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
|
18
|
Tabata RC, Wilson JMB, Ly P, Zwiegers P, Kwok D, Van Kampen JM, Cashman N, Shaw CA. Chronic exposure to dietary sterol glucosides is neurotoxic to motor neurons and induces an ALS-PDC phenotype. Neuromolecular Med 2008; 10:24-39. [PMID: 18196479 PMCID: PMC2814814 DOI: 10.1007/s12017-007-8020-z] [Citation(s) in RCA: 54] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/25/2007] [Accepted: 11/02/2007] [Indexed: 12/26/2022]
Abstract
Epidemiological studies of the Guamanian variants of amyotrophic lateral sclerosis (ALS) and parkinsonism, amyotrophic lateral sclerosis-parkinsonism dementia complex (ALS-PDC), have shown a positive correlation between consumption of washed cycad seed flour and disease occurrence. Previous in vivo studies by our group have shown that the same seed flour induces ALS and PDC phenotypes in out bred adult male mice. In vitro studies using isolated cycad compounds have also demonstrated that several of these are neurotoxic, specifically, a number of water insoluble phytosterol glucosides of which beta-sitosterol beta-D: -glucoside (BSSG) forms the largest fraction. BSSG is neurotoxic to motor neurons and other neuronal populations in culture. The present study shows that an in vitro hybrid motor neuron (NSC-34) culture treated with BSSG undergoes a dose-dependent cell loss. Surviving cells show increased expression of HSP70, decreased cytosolic heavy neurofilament expression, and have various morphological abnormalities. CD-1 mice fed mouse chow pellets containing BSSG for 15 weeks showed motor deficits and motor neuron loss in the lumbar and thoracic spinal cord, along with decreased glutamate transporter labelling, and increased glial fibrillary acid protein reactivity. Other pathological outcomes included increased caspase-3 labelling in the striatum and decreased tyrosine-hydroxylase labelling in the striatum and substantia nigra. C57BL/6 mice fed BSSG-treated pellets for 10 weeks exhibited progressive loss of motor neurons in the lumbar spinal cord that continued to worsen even after the BSSG exposure ended. These results provide further support implicating sterol glucosides as one potential causal factor in the motor neuron pathology previously associated with cycad consumption and ALS-PDC.
Collapse
Affiliation(s)
- R C Tabata
- Department of Experimental Medicine, University of British Columbia, Rm 386, 828 W.10th Ave, Vancouver, BC, Canada, V5Z1L8
| | | | | | | | | | | | | | | |
Collapse
|
19
|
Petrik MS, Wilson JMB, Grant SC, Blackband SJ, Tabata RC, Shan X, Krieger C, Shaw CA. Magnetic resonance microscopy and immunohistochemistry of the CNS of the mutant SOD murine model of ALS reveals widespread neural deficits. Neuromolecular Med 2007; 9:216-29. [PMID: 17914180 DOI: 10.1007/s12017-007-8002-1] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/26/2006] [Revised: 11/30/1999] [Accepted: 12/20/2006] [Indexed: 12/11/2022]
Abstract
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that primarily affects motor neurons and descending motor tracts of the CNS. We have evaluated the CNS of a murine model of familial ALS based on the over-expression of mutant human superoxide dismutase (mSOD; G93A) using magnetic resonance microscopy (MRM) and immunohistochemistry (IHC). Three-dimensional volumetric analysis was performed from 3D T2*-weighted images acquired at 17.6 T at isotropic resolutions of 40 mum. Compared to controls, mSOD mice had significant reductions in the volumes of total brain, substantia nigra, striatum, hippocampus, and internal capsule, with decreased cortical thickness in primary motor and somatosensory cortices. In the spinal cord, mSOD mice had significantly decreased volume of both the total grey and white matter; in the latter case, the volume change was confined to the dorsal white matter. Increased apoptosis, GFAP positive astrocytes, and/or activated microglia were observed in all those CNS regions that showed volume loss except for the hippocampus. The MRM findings in mSOD over-expressing mice are similar to data previously obtained from a model of ALS-parkinsonism dementia complex (ALS-PDC), in which neural damage occurred following a diet of washed cycad flour containing various neurotoxins. The primary difference between the two models involves a significantly greater decrease in spinal cord white matter volume in mSOD mice, perhaps reflecting variations in degeneration of the descending motor tracts. The extent to which several CNS structures are impacted in both murine models of ALS argues for a reevaluation of the nature of the pathogenesis of ALS since CNS structures involved in Parkinson's and Alzheimer's diseases appear to be affected as well.
Collapse
Affiliation(s)
- M S Petrik
- Program in Neuroscience, University of British Columbia, Vancouver, BC, Canada.
| | | | | | | | | | | | | | | |
Collapse
|
20
|
Abstract
Although sildenafil (Viagra) and other phosphodiesterase V (PDE V) inhibitors are increasingly recognized for their use in the treatment of male erectile dysfunction and perhaps more recently pulmonary artery hypertension, less is known of their potential beneficial effects in other situations. Medeiros et al., in the current issue of the British Journal of Pharmacology, report that sildenafil dramatically reduces alcohol-induced gastric damage in rats. The authors provide convincing evidence that such protection not only occurs via the nitric oxide (NO)/cGMP pathway, but also involves regulation of ATP-sensitive potassium channels. Therefore, in addition to exerting anti-impotence efficacy, PDE V inhibitors may provide significant beneficial effects from mucosal injury induced by alcohol.
Collapse
Affiliation(s)
- R Duffin
- MRC Centre for Inflammation Research, The Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK
| | | | | |
Collapse
|
21
|
Janáky R, Shaw CA, Oja SS, Saransaari P. Taurine release in developing mouse hippocampus is modulated by glutathione and glutathione derivatives. Amino Acids 2007; 34:75-80. [PMID: 17701096 PMCID: PMC2814815 DOI: 10.1007/s00726-007-0587-z] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/09/2007] [Accepted: 07/08/2007] [Indexed: 11/24/2022]
Abstract
Glutathione (reduced form GSH and oxidized form GSSG) constitutes an important defense against oxidative stress in the brain, and taurine is an inhibitory neuromodulator particularly in the developing brain. The effects of GSH and GSSG and glycylglycine, gamma-glutamylcysteine, cysteinylglycine, glycine and cysteine on the release of [(3)H]taurine evoked by K+-depolarization or the ionotropic glutamate receptor agonists glutamate, kainate, 2-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) and N-methyl-D-aspartate (NMDA) were now studied in slices from the hippocampi from 7-day-old mouse pups in a perfusion system. All stimulatory agents (50 mM K(+), 1 mM glutamate, 0.1 mM kainate, 0.1 mM AMPA and 0.1 mM NMDA) evoked taurine release in a receptor-mediated manner. Both GSH and GSSG significantly inhibited the release evoked by 50 mM K+. The release induced by AMPA and glutamate was also inhibited, while the kainate-evoked release was significantly activated by both GSH and GSSG. The NMDA-evoked release proved the most sensitive to modulation: L-Cysteine and glycine enhanced the release in a concentration-dependent manner, whereas GSH and GSSG were inhibitory at low (0.1 mM) but not at higher (1 or 10 mM) concentrations. The release evoked by 0.1 mM AMPA was inhibited by gamma-glutamylcysteine and cysteinylglycine, whereas glycylglycine had no effect. The 0.1 mM NMDA-evoked release was inhibited by glycylglycine and gamma-glutamylcysteine. In turn, cysteinylglycine inhibited the NMDA-evoked release at 0.1 mM, but was inactive at 1 mM. Glutathione exhibited both enhancing and attenuating effects on taurine release, depending on the glutathione concentration and on the agonist used. Both glutathione and taurine act as endogenous neuroprotective effectors during early postnatal life.
Collapse
Affiliation(s)
- R Janáky
- Brain Research Center, University of Tampere Medical School, Tampere, Finland
| | | | | | | |
Collapse
|
22
|
Wilson JMB, Shaw CA. Late appearance of glutamate transporter defects in a murine model of ALS–parkinsonism dementia complex. Neurochem Int 2007; 50:1067-77. [PMID: 17095122 DOI: 10.1016/j.neuint.2006.09.017] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2006] [Revised: 09/21/2006] [Accepted: 09/22/2006] [Indexed: 11/25/2022]
Abstract
Excitotoxicity has been widely hypothesized to play a major role in various neurodegenerative diseases. We have used a mouse model of ALS-parkinsonism dementia complex (ALS-PDC) of the Western Pacific to explore this hypothesis. Mice fed washed cycad flour, the major epidemiological link to ALS-PDC, showed significant and progressive motor, cognitive, and sensory behavioural deficits [Wilson, J.M., Khabazian, I., Wong, M.C., Seyedalikhani, A., Bains, J.S., Pasqualotto, B.A., Williams, D.E., Andersen, R.J., Simpson, R.J., Smith, R., Craig, U.K., Kurland, L.T., Shaw, C.A., 2002. Behavioral and neurological correlates of ALS-parkinsonism dementia complex in adult mice fed washed cycad flour. Neuromol. Med. 1 (3), 207-221]. In addition, glutamate transporter (GLT-1/EAAT2) levels measured by immunohistochemistry with antibodies specific for two glial glutamate transporter splice variants (GLT-1alpha and GLT-1B) were significantly down-regulated showing a 'patchy' loss of antibody label centered on blood vessels [Wilson, J.M., Khabazian, I., Pow, D.V., Craig, U.K., Shaw, C.A., 2003. Decrease in glial glutamate transporter variants and excitatory amino acid receptor down-regulation in a murine model of ALS-PDC. Neuromol. Med. 3 (2), 105-118]. Receptor binding assays showed decreased NMDA and AMPA receptor levels combined with increased GABA(A) receptor levels in various CNS regions. The alterations in GLT-1 variants and the ionotropic receptors are consistent with an increased level of extracellular glutamate. The interaction between environmental toxicity and genetic susceptibility was also tested using mice expressing various Apolipoprotein E (ApoE) genotypes. Mice lacking the ApoE gene showed relative resistance to cycad-induced toxicity as measured by GLT-1B labeling, but all mice expressing the human ApoE isoforms showed a similar loss of GLT-1B. We have further shown that an isolated cycad toxin (beta-sitosterol-beta-d-glucoside, BSSG), previously shown to release glutamate in vitro [Wilson, J.M., Khabazian, I., Wong, M.C., Seyedalikhani, A., Bains, J.S., Pasqualotto, B.A., Williams, D.E., Andersen, R.J., Simpson, R.J., Smith, R., Craig, U.K., Kurland, L.T., Shaw, C.A., 2002. Behavioral and neurological correlates of ALS-parkinsonism dementia complex in adult mice fed washed cycad flour. Neuromol. Med. 1 (3), 207-221], can be directly toxic to motor neurons in vivo [Wilson, J.M., Petrik, M.S., Moghadasian, M.H., Shaw, C.A., 2005. Examining the interaction of apo E and neurotoxicity on a murine model of ALS-PDC. Can. J. Physiol. Pharmacol. 83 (2), 131-141]. However, BSSG-fed mice did not show altered GLT-1B labeling in the spinal cord suggesting that an initial excitotoxic mechanism may not be responsible for the final neuronal loss observed. While glutamate-mediated excitotoxicity is likely involved in the outcomes following cycad/BSSG exposure, the precise location in the cascade of events ultimately leading to neuronal death remains to be determined.
Collapse
Affiliation(s)
- J M B Wilson
- University of British Columbia, Department of Neuroscience, 828 W10th Avenue, Rm 386, Vancouver, BC, Canada V5Z1L8.
| | | |
Collapse
|
23
|
Ly PTT, Singh S, Shaw CA. Novel environmental toxins: steryl glycosides as a potential etiological factor for age-related neurodegenerative diseases. J Neurosci Res 2007; 85:231-7. [PMID: 17149752 DOI: 10.1002/jnr.21147] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
Amyotrophic lateral sclerosis-parkinsonism dementia complex (ALS-PDC) is a unique neurodegenerative disease found on the island of Guam. This disease presents as a spectrum of neurological disorders characterized by features of ALS, parkinsonism, dementia, or a combination. The strongest epidemiological link has been to the consumption of the seeds from the cycad plant that purportedly contained a neurotoxin. Mice fed washed cycad flour show signs that mimic ALS-PDC, which include progressive deficits in motor, cognitive, and olfactory functions associated with neuron loss in the spinal cord, nigrostriatal system, cortex, hippocampus, and olfactory bulb. Through a series of chemical extractions of washed cycad flour, we identified steryl glycoside molecules as bioactive molecules that are neurotoxic in culture and in mice. A detailed review of this class of molecule revealed that the molecules are abundant in the environment, particularly in plants and bacteria. Lipid analysis showed that some bacteria that are associated with some forms of neurodegenerative disorders have the capacity to synthesize steryl glycosides. Furthermore, certain steryl glycosides have been found to be a cell stress mediator and may have some immunomodulary effects. We hypothesize that steryl glycosides are putative neurotoxins involved in the etiopathogenesis of several age-related neurodegenerative disorders.
Collapse
Affiliation(s)
- P T T Ly
- Department of Ophthalmology, The University of British Columbia, Vancouver, British Columbia, Canada
| | | | | |
Collapse
|
24
|
Schulz JD, Hawkes EL, Shaw CA. Cycad toxins, Helicobacter pylori and parkinsonism: cholesterol glucosides as the common denomenator. Med Hypotheses 2006; 66:1222-6. [PMID: 16488551 DOI: 10.1016/j.mehy.2004.12.033] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2004] [Accepted: 12/16/2004] [Indexed: 12/27/2022]
Abstract
Understanding sporadic cases of age-dependent neurodegenerative diseases such as parkinsonism requires the evaluation of potential environmental factors. Amyotrophic lateral sclerosis-parkinsonism dementia complex (ALS-PDC), a neurological disorder in which features of parkinsonism are present and for which no consistent genetic explanation has been found, has been linked to the consumption of cycad (Cycas micronesica). Similarly, epidemiological evidence suggests an association between parkinsonism and gastric ulcer caused by Helicobacter pylori infection. While common immunological and inflammatory changes have been proposed to account for the link between parkinsonism and H. pylori infection, we propose an alternate explanation based on our work on the "cycad theory" of ALS-PDC. Recent experiments in our laboratory have identified several sterol glucosides in cycad that have neurotoxic properties in vitro and that appear to be linked to the development of neurodegenerative disease in vivo. Specifically, mice fed cycad display behavioural symptoms of parkinsonism such as reduced gait length, as well as neuropathological signs such as a loss of striatal dopaminergic (DAergic) terminals and an upregulation of the dopamine D2 receptor. These cycad-derived sterol glucosides are structurally similar to cholesterol glucosides that account for a significant part pf the lipid profile of H. pylori. We hypothesize that cholesterol glucosides arising from H. pylori infection may act as neurotoxins, promoting the degeneration of the DAergic neurons affected in parkinsonism, in a similar reaction to that which is thought to link cycad consumption and ALS-PDC. This hypothesis will be tested in future studies that will include exposing mice to purified sterol or cholestorol glucosides derived from cycad and comparing these mice behaviourally and neuropathologically to ones chronically infected with H. pylori.
Collapse
Affiliation(s)
- J D Schulz
- Department of Ophthalmology, University of British Columbia, Vancouver, Canada
| | | | | |
Collapse
|
25
|
Sinnreich M, Shaw CA, Pari G, Nalbantoglu J, Holland PC, Karpati G. Localization of coxsackie virus and adenovirus receptor (CAR) in normal and regenerating human muscle. Neuromuscul Disord 2005; 15:541-8. [PMID: 16014330 DOI: 10.1016/j.nmd.2005.05.007] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/21/2005] [Revised: 05/17/2005] [Accepted: 05/20/2005] [Indexed: 10/25/2022]
Abstract
The primary receptor for Adenovirus and Coxsackie virus (CAR) serves as main port of entry of the adenovirus vector mediating gene transfer into skeletal muscle. Information about CAR expression in normal and diseased human skeletal muscle is lacking. C'- or N'-terminally directed polyclonal antibodies against CAR were generated and immunohistochemical analysis of CAR on morphologically normal and regenerating human skeletal muscle of children and adults was performed. In morphologically normal human muscle fibers, CAR immunoreactivity was limited to the neuromuscular junction. In regenerating muscle fibers, CAR was abundantly co-expressed with markers of regeneration. The function of CAR at the neuromuscular junction is currently unknown. Co-expression of CAR with markers of regeneration suggests that CAR is developmentally regulated, and may serve as a marker of skeletal muscle fiber regeneration.
Collapse
Affiliation(s)
- M Sinnreich
- Neuromuscular Research Group, Montreal Neurological Hospital and Institute, McGill University, 3801 University Street, Montreal, Que., Canada H3A 2B4
| | | | | | | | | | | |
Collapse
|
26
|
Wilson JMB, Petrik MS, Moghadasian MH, Shaw CA. Examining the interaction of apo E and neurotoxicity on a murine model of ALS-PDC. Can J Physiol Pharmacol 2005; 83:131-41. [PMID: 15791286 DOI: 10.1139/y04-140] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Epidemiological studies have shown a positive relationship between cycad flour consumption and the development of the neurodegenerative disorder, amyotrophic lateral sclerosis – parkinsonism – dementia complex (ALS-PDC). Apolipoprotein E (apo E) allele variations have been associated with genetic susceptibility in neurodegenerative diseases, including ALS-PDC. We have studied cycad toxicity in a mouse model of ALS-PDC with a particular interest in its impact on the central nervous system (CNS) in both apo E knock-out (KO) mice and their wild-type (WT) counterparts. Behavioral motor tests, motor neuron counts, and immunohistochemical staining in brain and spinal cord, as well as routine histological examinations on internal organs, were performed to evaluate cycad toxicity. Plasma cholesterol levels were also measured before and during the study. Cycad treatment was associated with higher levels of plasma cholesterol only in apo E KO mice; increased levels of plasma cholesterol did not result in increased athero genesis. Cycad-fed wild-type mice developed progressive behavioral deficits including ALS-PDC-like pathological outcomes, while cycad-fed apo E KO mice were not significantly affected. Cycad-fed wild-type mice had shorter gait length measurements along with higher active caspase-3 levels in the striatum, substantia nigra, primary motor cortex, and spinal cord as compared with corresponding controls. These changes were associated with decreased labeling for glutamate transporter 1B and tyrosine hydroxylase activity levels. No evidence of cycad toxicity was observed in internal organs of either wild-type or apo E KO mice. Our data demonstrate that apo E KO mice are less susceptible to cycad toxicity, suggesting a role for apo E as a possible genetic susceptibility factor for some forms of toxin-induced neurodegeneration.Key words: apolipoprotein E, amyotrophic lateral sclerosis (ALS), ALS-parkinsonism dementia complex (ALS-PDC), parkinsonism, dementia, neurodegeneration, glutamate transporter, sterol, sterol glucoside.
Collapse
Affiliation(s)
- J M B Wilson
- Department of Opthalmology and Program in Neuroscience, University of British Columbia, Vancouver, Canada
| | | | | | | |
Collapse
|
27
|
Wilson JMB, Petrik MS, Grant SC, Blackband SJ, Lai J, Shaw CA. Quantitative measurement of neurodegeneration in an ALS–PDC model using MR microscopy. Neuroimage 2004; 23:336-43. [PMID: 15325381 DOI: 10.1016/j.neuroimage.2004.05.026] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/05/2004] [Revised: 04/15/2004] [Accepted: 05/24/2004] [Indexed: 12/11/2022] Open
Abstract
Exposure to cycad (Cycas micronesica K.D. Hill) toxins via diet has been shown to induce neurodegeneration in vivo that mimics the progressive neurological disease, amyotrophic lateral sclerosis--parkinsonism dementia complex (ALS--PDC). In previous studies, specific cortical and subcortical cell loss was measured with conventional stained sections. In the present study, magnetic resonance (MR) microscopy was used to examine neurodegeneration in three dimensions (3D) in isolated intact brains and spinal cords. Mice were fed washed cycad for 2 months and showed progressive motor deficits resembling human ALS--PDC. CNS tissue was imaged at 17.6 T. T2* scans were acquired on both spinal cord and brain samples with an isotropic resolution of 41 microm. Through MR volumetrics, cycad-fed mice showed significantly decreased volumes in lumbar spinal cord gray matter, substantia nigra, striatum, basal nucleus/internal capsule, and olfactory bulb. Cortical measurements of conventionally stained sections revealed that cycad-fed mice also showed decreased cortical thickness. These results show that MR microscopy (MRM) is sensitive enough to measure degeneration in this early stage model of a progressive neurological disease with strong correlations to behavioral deficits and histological results and may be applicable in vivo to the same model. Similar analysis may be used in the future as a diagnostic aid in tracking the early progression of neurological disorders in preclinical human subjects.
Collapse
Affiliation(s)
- J M B Wilson
- Program in Neuroscience, University of British Columbia Vancouver, BC, Canada
| | | | | | | | | | | |
Collapse
|
28
|
Shaw CJ, Shaw CA, Yu W, Stankiewicz P, White LD, Beaudet AL, Lupski JR. Comparative genomic hybridisation using a proximal 17p BAC/PAC array detects rearrangements responsible for four genomic disorders. J Med Genet 2004; 41:113-9. [PMID: 14757858 PMCID: PMC1735660 DOI: 10.1136/jmg.2003.012831] [Citation(s) in RCA: 60] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
BACKGROUND Proximal chromosome 17p is a region rich in low copy repeats (LCRs) and prone to chromosomal rearrangements. Four genomic disorders map within the interval 17p11-p12: Charcot-Marie-Tooth disease type 1A, hereditary neuropathy with liability to pressure palsies, Smith-Magenis syndrome, and dup(17)(p11.2p11.2) syndrome. While 80-90% or more of the rearrangements resulting in each disorder are recurrent, several non-recurrent deletions or duplications of varying sizes within proximal 17p also have been characterised using fluorescence in situ hybridisation (FISH). METHODS A BAC/PAC array based comparative genomic hybridisation (array-CGH) method was tested for its ability to detect these genomic dosage differences and map breakpoints in 25 patients with recurrent and non-recurrent rearrangements. RESULTS Array-CGH detected the dosage imbalances resulting from either deletion or duplication in all the samples examined. The array-CGH approach, in combination with a dependent statistical inference method, mapped 45/46 (97.8%) of the analysed breakpoints to within one overlapping BAC/PAC clone, compared with determinations done independently by FISH. Several clones within the array that contained large LCRs did not have an adverse effect on the interpretation of the array-CGH data. CONCLUSIONS Array-CGH is an accurate and sensitive method for detecting genomic dosage differences and identifying rearrangement breakpoints, even in LCR-rich regions of the genome.
Collapse
MESH Headings
- Centromere/genetics
- Chromosome Breakage/genetics
- Chromosome Deletion
- Chromosome Mapping/methods
- Chromosome Mapping/statistics & numerical data
- Chromosomes, Artificial, Bacterial/genetics
- Chromosomes, Artificial, P1 Bacteriophage/genetics
- Chromosomes, Human, Pair 17/genetics
- DNA/genetics
- Electrophoresis, Gel, Pulsed-Field/standards
- Female
- Gene Duplication
- Genetic Diseases, Inborn/genetics
- Humans
- In Situ Hybridization, Fluorescence/standards
- Male
- Mutation/genetics
- Nucleic Acid Hybridization
- Oligonucleotide Array Sequence Analysis/methods
- Oligonucleotide Array Sequence Analysis/statistics & numerical data
Collapse
Affiliation(s)
- C J Shaw
- Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA
| | | | | | | | | | | | | |
Collapse
|
29
|
Abstract
The causal factor(s) responsible for sporadic neurological diseases are unknown and the stages of disease progression remain undefined and poorly understood. We have developed an animal model of amyotrophic lateral sclerosis-parkinsonism dementia complex which mimics all the essential features of the disease with the initial neurological insult arising from neurotoxins contained in washed cycad seeds. Animals fed washed cycad develop deficits in motor, cognitive, and sensory behaviors that correlate with the loss of neurons in specific regions of the central nervous system. The ability to recreate the disease by exposure to cycad allows us to extend the model in multiple dimensions by analyzing behavioral, cellular, and biochemical changes over time. In addition, the ability to induce toxin-based neurodegeneration allows us to probe the interactions between genetic and epigenetic factors. Our results show that the impact of both genetic causal and susceptibility factors with the cycad neurotoxins are complex. The article describes the features of the model and suggests ways that our understanding of cycad-induced neurodegeneration can be used to decipher and identify the early events in various human neurological diseases.
Collapse
Affiliation(s)
- C A Shaw
- Program in Neuroscience, University of British Columbia, Vancouver, BC, Canada.
| | | |
Collapse
|
30
|
Khabazian I, Bains JS, Williams DE, Cheung J, Wilson JMB, Pasqualotto BA, Pelech SL, Andersen RJ, Wang YT, Liu L, Nagai A, Kim SU, Craig UK, Shaw CA. Isolation of various forms of sterol beta-D-glucoside from the seed of Cycas circinalis: neurotoxicity and implications for ALS-parkinsonism dementia complex. J Neurochem 2002; 82:516-28. [PMID: 12153476 DOI: 10.1046/j.1471-4159.2002.00976.x] [Citation(s) in RCA: 92] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
The factors responsible for ALS-parkinsonism dementia complex (ALS-PDC), the unique neurological disorder of Guam, remain unresolved, but identification of causal factors could lead to clues for related neurodegenerative disorders elsewhere. Earlier studies focused on the consumption and toxicity of the seed of Cycas circinalis, a traditional staple of the indigenous diet, but found no convincing evidence for toxin-linked neurodegeneration. We have reassessed the issue in a series of in vitro bioassays designed to isolate non-water soluble compounds from washed cycad flour and have identified three sterol beta-d-glucosides as potential neurotoxins. These compounds give depolarizing field potentials in cortical slices, induce alterations in the activity of specific protein kinases, and cause release of glutamate. They are also highly toxic, leading to release of lactate dehydrogenase (LDH). Theaglycone form, however, is non-toxic. NMDA receptor antagonists block the actions of the sterol glucosides, but do not compete for binding to the NMDA receptor. The most probable mechanism leading to cell death may involve glutamate neuro/excitotoxicity. Mice fed cycad seed flour containing the isolated sterol glucosides show behavioral and neuropathological outcomes, including increased TdT-mediated biotin-dUTP nick-end labelling (TUNEL) positivity in various CNS regions. Astrocytes in culture showed increased caspase-3 labeling after exposure to sterol glucosides. The present results support the hypothesis that cycad consumption may be an important factor in the etiology of ALS-PDC and further suggest that some sterol glucosides may be involved in other neurodegenerative disorders.
Collapse
Affiliation(s)
- I Khabazian
- Department of Ophthalmology, University of British Columbia, Vancouver, Canada
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
31
|
Sogo N, Magid KS, Shaw CA, Webb DJ, Megson IL. Inhibition of human platelet aggregation by nitric oxide donor drugs: relative contribution of cGMP-independent mechanisms. Biochem Biophys Res Commun 2000; 279:412-9. [PMID: 11118301 DOI: 10.1006/bbrc.2000.3976] [Citation(s) in RCA: 90] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Inhibition of platelet activation by nitric oxide (NO) is not exclusively cGMP-dependent. Here, we tested whether inhibition of platelet aggregation by structurally distinct NO donors is mediated by different mechanisms, partly determined by the site of NO release. Glyceryl trinitrate (GTN), sodium nitroprusside (SNP), S-nitrosoglutathione (GSNO), diethylamine diazeniumdiolate (DEA/NO), and a novel S-nitrosothiol, RIG200, were examined in ADP (8 microM)- and collagen (2.5 microgram/ml)-activated human platelet rich plasma. GTN was a poor inhibitor of aggregation whilst the other NO donors inhibited aggregation, irrespective of agonist. These effects were abolished by the NO scavenger, hemoglobin (Hb; 10 microM, P < 0.05, n = 6), except with high concentrations of DEA/NO, when NO concentrations exceeded the capacity of Hb. However, experiments with the soluble guanylate cyclase inhibitor, ODQ (100 microM), indicated that only SNP-mediated inhibition was exclusively cGMP-dependent. Furthermore, the cGMP-independent effects of S-nitrosothiols were distinct from those of DEA/NO, suggesting that different NO-related mediators (e.g., nitrosonium and peroxynitrite, respectively) are responsible for their actions.
Collapse
Affiliation(s)
- N Sogo
- Endothelial Cell Biology and Molecular Cardiology Group, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom
| | | | | | | | | |
Collapse
|
32
|
Pasqualotto BA, Shaw CA. Introduction: tuning the signal: regulation of postsynaptic receptor properties. Cell Mol Life Sci 2000; 57:1495-8. [PMID: 11092443 DOI: 10.1007/pl00000633] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- B A Pasqualotto
- Department of Physiology, University of British Columbia, Vancouver, Canada
| | | |
Collapse
|
33
|
Abstract
It has been suggested that in vitro selection experiments can provide information not only on what might have occurred during the evolution of the RNA world, but can in fact yield insights into particular features of the RNA world. In particular, it has been suggested that the sequences of anti-amino acid aptamers can provide clues to the origin of the genetic code, and that there is a statistically significant association between motifs found in aptamers and codons. We argue that the suggested connections between modern motifs and ancient sequences are logically tenuous, and show that there is no statistically meaningful association between motifs found in aptamers and codons.
Collapse
Affiliation(s)
- A D Ellington
- Department of Chemistry and Biochemistry, University of Texas at Austin, 78712, USA.
| | | | | |
Collapse
|
34
|
Abstract
Glutathione (gamma-glutamylcysteinylglycine) is a neuromodulator at glutamate receptors, but may also act as a neurotransmitter at sites of its own. The Na+-independent binding of [3H]glutathione to pig cortical synaptic membranes was characterized here using glycine, cysteine analogs, dipeptides and glutathione derivatives, and ligands selective for known glutamate receptors. L-Glutamate, pyroglutamate, quinolinate, (S)-5-fluorowillardiine and 6-nitro-7-sulfamoylbenzo[f]quinoxaline-2,3-dione were weak inhibitors at concentrations of 0.5 or 1 mM. D-Glutamate, L- and D-aspartate, glutamine, quisqualate, kynurenate, other N-methyl-D-aspartate receptor ligands and non-N-methyl-D-aspartate receptor ligands failed to displace [3H]glutathione. Except for weak inhibition by D-serine (0.5 mM), glycine and other ligands of the glycine co-activatory site in the N-methyl-D-aspartate receptors had no displacing effect. Similarly, metabotropic glutamate group I, II and III receptor agonists and antagonists and compounds acting at the glutamate uptake sites were generally inactive. Glutathione, oxidized glutathione, S-nitrosoglutathione, gamma-L-glutamylcysteine, cysteinylglycine, cysteine, cysteamine and cystamine were the most potent displacers (IC50 values in the micromolar range), followed by dithiothreitol, glutathione sulfonate and the S-alkyl derivatives of glutathione (S-methyl-, -ethyl-, -propyl-, -butyl- and -pentylglutathione). L-Homocysteinate and aminomethanesulfonate exhibited a moderate efficacy. Thiokynurenate, a cysteine analog and an antagonist at the N-methyl-D-aspartate receptor glycine co-activatory site, was a potent activator of glutathione binding. At 1 mM, some dipeptides also slightly activated the binding, gamma-L-glutamylleucine and gamma-L-glutamyl-GABA being the most effective. The specific binding sites for glutathione in brain synaptic membranes are not identical to any known excitatory amino acid receptor. The cysteinyl moiety is crucial in the binding of glutathione. The oxidation or alkylation of the cysteine thiol group reduces the binding affinity. The strong activation by thiokynurenate may indicate that the glutathione receptor protein contains a modulatory site to which co-agonists may bind and allosterically activate glutathione binding. The novel population of specific binding sites of glutathione gives rise to the possibility that they may have profound effects on synaptic functions in the mammalian central nervous system. The glutathione binding sites may be an important, and for the most part unrecognized, component in signal transduction in the brain.
Collapse
Affiliation(s)
- R Janáky
- Tampere Brain Research Center, University of Tampere Medical School, Finland.
| | | | | | | | | | | | | |
Collapse
|
35
|
Shaw CA, Kelleher AA, Gill CP, Murdoch LJ, Stables RH, Black AE. Comparison of the incidence of complications at induction and emergence in infants receiving oral atropine vs no premedication. Br J Anaesth 2000; 84:174-8. [PMID: 10743449 DOI: 10.1093/oxfordjournals.bja.a013399] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
We studied 120 patients less than 1 yr of age, allocated randomly to receive atropine 40 micrograms kg-1 orally 1 h before operation (group A) or no premedication (group B). All patients underwent a standardized anaesthetic, including inhalation induction with halothane followed by atracurium 0.5 mg kg-1, tracheal intubation and positive pressure ventilation. Monitoring during anaesthesia included heart rate, arterial oxygen saturation, temperature and airway conditions at induction and emergence. The incidence of a decrease in arterial oxygen saturation to 94% or less at induction and recovery was similar in both groups (30.5% at induction, 39% at extubation in group A; 31% at induction, 41% at extubation in group B). There were significantly more airway complications in group B both at induction and emergence (25% and 49%, respectively, compared with 9% and 25% in group A; P < 0.015). Mean heart rate at induction and in the peroperative period was significantly higher in the group receiving atropine (P < or = 0.001). There was an increased incidence of bradycardia (decrease in heart rate of > or = 20%) at induction in the non-premedicated group (23% in group B compared with 10% in group A), but this was not statistically significant. We conclude that the incidence of airway complications at induction and emergence was reduced by orally administered atropine premedication.
Collapse
Affiliation(s)
- C A Shaw
- Department of Anaesthesia, Great Ormond Street Hospital for Children NHS Trust, London, UK
| | | | | | | | | | | |
Collapse
|
36
|
Shaw CA, Bains JS, Pasqualotto BA, Curry K. Methionine sulfoximine shows excitotoxic actions in rat cortical slices. Can J Physiol Pharmacol 1999; 77:871-7. [PMID: 10593660] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/14/2023]
Abstract
Methionine sulfoximine (MSO) is a rare amino acid. It occurs in nature or as a by-product of some forms of food processing. A notable example of the latter was a former method for bleaching wheat flour, using nitrogen trichloride, the "agene process," in use for most of the first 50 years of this century. "Agenized" flour was found to be responsible for various neurological disorders in animals, and MSO was identified as the toxic factor. The agene process was subsequently discontinued in the United States and the United Kingdom circa 1950. MSO inhibits the synthesis of both glutathione and glutamine, and it is possible that its actions on the nervous system arise from alterations in the amount or distribution of these molecules. Structurally, MSO resembles glutamate, an observation that has also raised the possibility that it might have more direct glutamate-like actions on neurons. In the present investigation, we report excitatory and toxic actions of MSO in an in vitro preparation of adult rat cortex. Field potential recordings in this preparation show that MSO application evokes a sustained depolarization, which can be blocked by the N-methyl-D-aspartate (NMDA) antagonist L-(+)-2-amino-5-phosphonovalerate (AP5). However, competition assays using MSO on [3H]CGP-39653 (DL-(E)-2-amino-4-propyl-1-phosphono-3-pentenoate) binding in rat cortical homogenates show only 20% displacement of total binding, suggesting that MSO is acting indirectly, perhaps by releasing glutamate. To investigate this possibility, we measured glutamate release during MSO application. Time course and dose-response experiments with MSO showed significant [3H]glutamate release, which was partially attenuated by AP5. To assess cellular toxicity, we measured lactate dehydrogenase (LDH) release from cortical sections exposed to MSO. MSO treatment led to a rapid increase in LDH activity, which could be blocked by AP5. These data suggest that MSO acts by increasing glutamate release, which then activates NMDA receptors, leading to excitotoxic cell death. These data suggest the possibility that MSO in processed flour had excitotoxic actions that may have been contributing factors to some human neuronal disorders.
Collapse
Affiliation(s)
- C A Shaw
- Department of Ophthalmology, The University of British Columbia, Vancouver, Canada.
| | | | | | | |
Collapse
|
37
|
Abstract
In an attempt to develop various fluorescent probes to label glutathione (GSH) receptors, we have serendipitously synthesized a probe that binds to and antagonizes the NMDA receptor. Probe 1, a GSH adduct, displaces the competitive NMDA antagonist [3H]-CGP 39653 with a higher affinity than NMDA or cysteine in rat synaptic membranes. In recording experiments from a rat cortical 'wedge' preparation, Probe 1 reversibly blocks both NMDA- and cysteine-induced depolarization. In mixed astrocyte-neuron tissue culture preparations, Probe 1 labels parts of both cell bodies as well as processes. The present data suggest that Probe 1 binds to the NMDA receptor and antagonizes channel function.
Collapse
Affiliation(s)
- C A Shaw
- Department of Ophthalmology, c/o Department of Anatomy, University of British Columbia, Vancouver, Canada.
| | | | | | | | | | | |
Collapse
|
38
|
Shaw CA, Bains JS, Pasqualotto BA, Curry K. Methionine sulfoximine shows excitotoxic actions in rat cortical slices. Can J Physiol Pharmacol 1999. [DOI: 10.1139/y99-097] [Citation(s) in RCA: 20] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Methionine sulfoximine (MSO) is a rare amino acid. It occurs in nature or as a by-product of some forms of food processing. A notable example of the latter was a former method for bleaching wheat flour, using nitrogen trichloride, the "agene process," in use for most of the first 50 years of this century. "Agenized" flour was found to be responsible for various neurological disorders in animals, and MSO was identified as the toxic factor. The agene process was subsequently discontinued in the United States and the United Kingdom circa 1950. MSO inhibits the synthesis of both glutathione and glutamine, and it is possible that its actions on the nervous system arise from alterations in the amount or distribution of these molecules. Structurally, MSO resembles glutamate, an observation that has also raised the possibility that it might have more direct glutamate-like actions on neurons. In the present investigation, we report excitatory and toxic actions of MSO in an in vitro preparation of adult rat cortex. Field potential recordings in this preparation show that MSO application evokes a sustained depolarization, which can be blocked by the N-methyl-D-aspartate (NMDA) antagonist L-(+)-2-amino-5-phosphonovalerate (AP5). However, competition assays using MSO on [3H]CGP-39653 (DL-(E)-2-amino-4-propyl-1-phosphono-3-pentenoate) binding in rat cortical homogenates show only 20% displacement of total binding, suggesting that MSO is acting indirectly, perhaps by releasing glutamate. To investigate this possibility, we measured glutamate release during MSO application. Time course and dose-response experiments with MSO showed significant [3H]glutamate release, which was partially attenuated by AP5. To assess cellular toxicity, we measured lactate dehydrogenase (LDH) release from cortical sections exposed to MSO. MSO treatment led to a rapid increase in LDH activity, which could be blocked by AP5. These data suggest that MSO acts by increasing glutamate release, which then activates NMDA receptors, leading to excitotoxic cell death. These data suggest the possibility that MSO in processed flour had excitotoxic actions that may have been contributing factors to some human neuronal disorders.Key words: agene process, glutamate release, lactate dehydrogenase, methionine sulfoximine, N-methyl-D-aspartate (NMDA) receptor, neurological disorders.
Collapse
|
39
|
McEachern JC, Shaw CA. The plasticity-pathology continuum: defining a role for the LTP phenomenon. J Neurosci Res 1999; 58:42-61. [PMID: 10491571] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/14/2023]
Abstract
Long-term potentiation (LTP) is the most widely studied form of neuroplasticity and is believed by many in the field to be the substrate for learning and memory. For this reason, an understanding of the mechanisms underlying LTP is thought to be of fundamental importance to the neurosciences, but a definitive linkage of LTP to learning or memory has not been achieved. Much of the correlational data used to support this claim is ambiguous and controversial, precluding any solid conclusion about the functional relevance of this often artificially induced form of neuroplasticity. In spite of this fact, the belief that LTP is a mechanism subserving learning and/or memory has become so dominant in the field that the investigation of other potential roles or actions of LTP-like phenomena in the nervous system has been seriously hindered. The multiple subtypes of the phenomena and the myriad molecules apparently involved in these subtypes raise the possibility that observed forms of LTP may represent very different types of modification events, with vastly different consequences for neural function and survival. A relationship between LTP and neuropathology is suggested in part by the fact that many of the molecular processes involved in LTP induction or maintenance are the same as those activated during excitotoxic events in neurons. In addition, some LTP subtypes are clearly induced by pathological stimuli, e.g., anoxic LTP. Such data raise the possibility that LTP is part of a continuum of types of neural modification, some leading to beneficial alterations such as may occur in learning and others that may be primarily pathological in nature, as in kindling and excitotoxicity. In this article, we introduce a plasticity-pathology continuum model that is designed to place the various forms of neural modification into proper context. In vitro and kindling receptor regulation studies are used to provide a basis for evaluating the specific synaptic/cellular response modification along the continuum of events, from beneficial to detrimental, that will be induced by a particular stimulus.
Collapse
Affiliation(s)
- J C McEachern
- Department of Physiology, University of British Columbia, Vancouver, Canada.
| | | |
Collapse
|
40
|
Abstract
The tripeptide glutathione (GSH) has been thoroughly investigated in relation to its role as antioxidant and free radical scavenger. In recent years, novel actions of GSH in the nervous system have also been described, suggesting that GSH may serve additionally both as a neuromodulator and as a neurotransmitter. In the present article, we describe our studies to explore further a potential role of GSH as neuromodulator/neurotransmitter. These studies have used a combination of methods, including radioligand binding, synaptic release and uptake assays, and electrophysiological recording. We report here the characteristics of GSH binding sites, the interrelationship of GSH with the NMDA receptor, and the effects of GSH on neural activity. Our results demonstrate that GSH binds via its gamma-glutamyl moiety to ionotropic glutamate receptors. At micromolar concentrations GSH displaces excitatory agonists, acting to halt their physiological actions on target neurons. At millimolar concentrations, GSH, acting through its free cysteinyl thiol group, modulates the redox site of NMDA receptors. As such modulation has been shown to increase NMDA receptor channel currents, this action may play a significant role in normal and abnormal synaptic activity. In addition, GSH in the nanomolar to micromolar range binds to at least two populations of binding sites that appear to be distinct from all known excitatory amino acid receptor subtypes. GSH bound to these sites is not displaceable by glutamatergic agonists or antagonists. These binding sites, which we believe to be distinct receptor populations, appear to recognize the cysteinyl moiety of the GSH molecule. Like NMDA receptors, the GSH binding sites possess a coagonist site(s) for allosteric modulation. Furthermore, they appear to be linked to sodium ionophores, an interpretation supported by field potential recordings in rat cerebral cortex that reveal a dose-dependent depolarization to applied GSH that is blocked by the absence of sodium but not by lowering calcium or by NMDA or (S)-2-amino-3-hydroxy-5-methyl-4-isoxazolepropionate antagonists. The present data support a reevaluation of the role of GSH in the nervous system in which GSH may be involved both directly and indirectly in synaptic transmission. A full accounting of the actions of GSH may lead to more comprehensive understanding of synaptic function in normal and disease states.
Collapse
Affiliation(s)
- R Janáky
- Tampere Brain Research Center, Finland
| | | | | | | | | | | | | |
Collapse
|
41
|
Kadavy DR, Plantz B, Shaw CA, Myatt J, Kokjohn TA, Nickerson KW. Microbiology of the oil fly, Helaeomyia petrolei. Appl Environ Microbiol 1999; 65:1477-82. [PMID: 10103240 PMCID: PMC91210 DOI: 10.1128/aem.65.4.1477-1482.1999] [Citation(s) in RCA: 18] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/1998] [Accepted: 01/03/1999] [Indexed: 11/20/2022] Open
Abstract
Helaeomyia petrolei larvae isolated from the asphalt seeps of Rancho La Brea in Los Angeles, Calif., were examined for microbial gut contents. Standard counts on Luria-Bertani, MacConkey, and blood agar plates indicated ca. 2 x 10(5) heterotrophic bacteria per larva. The culturable bacteria represented 15 to 20% of the total population as determined by acridine orange staining. The gut itself contained large amounts of the oil, had no observable ceca, and maintained a slightly acidic pH of 6.3 to 6.5. Despite the ingestion of large amounts of potentially toxic asphalt by the larvae, their guts sustained the growth of 100 to 1,000 times more bacteria than did free oil. All of the bacteria isolated were nonsporeformers and gram negative. Fourteen isolates were chosen based on representative colony morphologies and were identified by using the Enterotube II and API 20E systems and fatty acid analysis. Of the 14 isolates, 9 were identified as Providencia rettgeri and 3 were likely Acinetobacter isolates. No evidence was found that the isolates grew on or derived nutrients from the asphalt itself or that they played an essential role in insect development. Regardless, any bacteria found in the oil fly larval gut are likely to exhibit pronounced solvent tolerance and may be a future source of industrially useful, solvent-tolerant enzymes.
Collapse
Affiliation(s)
- D R Kadavy
- School of Biological Sciences, University of Nebraska, Lincoln, Nebraska 68588-0666, USA
| | | | | | | | | | | |
Collapse
|
42
|
Abstract
The present report proposes the hypothesis that increased levels of neurodegenerative disorders in humans may have arisen due to inclusion in the diet of methionine sulfoximine (MSO), a byproduct of the bleaching of flour by nitrogen trichloride. This method of bleaching, the 'agene process' was in use from early in the century and continued until at least 1949/1950. Estimates indicate that, at least in the UK, as much as 80% of all flour during this period was produced by this process. MSO acts directly to inhibit the production of two crucial molecules, glutathione (GSH) and glutamine. Decreases in GSH, a key antioxidant and free radical scavenger, diminish the body's antioxidant defenses and may lead to increased oxidative stress. Decreases in glutamine synthesis may act to increase free glutamate and give rise to increased levels of ammonia. Cells in the nervous system are particularly sensitive to a decline in either GSH or glutamine. The combined effects of decreases in these molecules, particularly with long-term exposure to MSO in bleached flour, may have had quite drastic effects on neuronal health and survival. The present hypothesis may provide clues to the etiology of neurological disorders such as Alzheimer's disease (AD), Parkinson's disease (PD) and amyotrophic lateral sclerosis (ALS), suggesting that such disorders may arise in part due to toxic actions of some compounds in processed human foods.
Collapse
Affiliation(s)
- C A Shaw
- Department of Ophthalmology, University of British Columbia, Vancouver, Canada.
| | | |
Collapse
|
43
|
Abstract
Previous studies have demonstrated a significant reduction of N-methyl-D-aspartate (NMDA) receptor binding in spinal cord sections from patients who died with amyotrophic lateral sclerosis (ALS) compared to that in control patients. The reduction in NMDA receptor binding in ALS could be increased toward control values by treatment with phorbol ester, suggesting a role for receptor protein phosphorylation in this disorder. In the present study we have evaluated the time course of recovery of [3H]MK-801 binding following phorbol ester treatment to assess protein phosphatase activity in spinal cord sections from ALS and control subjects. Phorbol ester-stimulated changes in [3H]MK-801 binding returned to untreated values significantly faster in ALS tissue compared to control and could not be blocked by the coapplication of the protein phosphatase inhibitors sodium vanadate or sodium beta-D-glycerol phosphate. Okadaic acid coapplication blocked recovery in both ALS and control tissue at a concentration range at which phosphatase 2B (calcineurin) would likely be inhibited. The results suggest that abnormal levels or activity of protein phosphatases, including calcineurin, may be involved in the abnormal levels of NMDA receptors in ALS and may play some role in the pathogenesis of the disease.
Collapse
Affiliation(s)
- R Wagey
- Department of Medicine, University of British Columbia, Vancouver, Canada
| | | | | |
Collapse
|
44
|
Abstract
Oxidative stress has been implicated in both normal aging and in various neurodegenerative disorders and may be a common mechanism underlying various forms of cell death including necrosis, apoptosis, and excitotoxicity. In this review, we develop the hypothesis that oxidative stress-mediated neuronal loss may be initiated by a decline in the antioxidant molecule glutathione (GSH). GSH plays multiple roles in the nervous system including free radical scavenger, redox modulator of ionotropic receptor activity, and possible neurotransmitter. GSH depletion can enhance oxidative stress and may also increase the levels of excitotoxic molecules; both types of action can initiate cell death in distinct neuronal populations. Evidence for a role of oxidative stress and diminished GSH status is presented for Lou Gehrig's disease (ALS), Parkinson's disease, and Alzheimer's disease. Potential links to the Guamanian variant of these diseases (ALS-PD complex) are discussed. In context to the above, we provide a GSH-depletion model of neurodegenerative disorders, suggest experimental verifications of this model, and propose potential therapeutic approaches for preventing or halting these diseases.
Collapse
Affiliation(s)
- J S Bains
- Department of Ophthalmology, The University of British Columbia, Vancouver, Canada.
| | | |
Collapse
|
45
|
Abstract
The regulation of synaptic signal transduction is of central importance to our understanding of normal and abnormal nervous system function. One mechanism by which signal transduction can be affected is the modification of cellular sensitivity by alterations of transmembrane receptor properties. For G-protein coupled receptors, protein phosphorylation is intimately involved in many stages of receptor regulation. This appears to be true for ionotropic receptors as well. Evidence of a role for protein kinase and protein phosphatase activity in the multi-staged ionotropic receptor regulation cascade is presented and a comparison to G-protein coupled receptor regulation is considered.
Collapse
Affiliation(s)
- B A Pasqualotto
- Department of Physiology, University of British Columbia, Vancouver, Canada
| | | |
Collapse
|
46
|
McEachern JC, Shaw CA. An alternative to the LTP orthodoxy: a plasticity-pathology continuum model. Brain Res Brain Res Rev 1996; 22:51-92. [PMID: 8871785] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
Long-term potentiation (LTP) is probably the most widely studied form of synaptic plasticity in the mammalian central nervous system. In the early descriptions, the term referred to a sustained increase in synaptic response following a brief high-frequency electrical tetanus. Apparently unique properties of the phenomenon triggered considerable excitement in the field: for many, LTP offered the promise of a potential substrate for learning and/or memory. In the more than 20 years since LTP was first discovered, investigators motivated by this promise have described a vast array of molecules and processes that may be involved in LTP induction and maintenance. And yet, the mechanisms by which LTP occurs have not been resolved. Instead, the compiled results have uncovered layer upon layer of intricacy, including multiple LTP forms and multiple molecular cascades involved in LTP expression. The generally stated thesis that LTP equates to learning and/or memory at a synaptic level has not faced a serious challenge despite the fact that workers in the field have not provided an unambiguous correlation of LTP with either. A number of investigators have now shifted their attention to a newer form of synaptic modification, long-term depression (LTP). Whatever studies of LTD reveal, it is clear that the fundamental questions about LTP remain unanswered: what is it really and what, if anything, is it used for? In this review, we summarize the data concerning putative LTP mechanisms and the evidence for LTP's role in learning and memory. We show that extant models are not sufficient to account for the various forms of LTP and that the experimental evidence does not justify the view that LTP equates to learning and memory. Instead, we suggest that LTP can be related to other forms of synaptic modification, e.g., LTD and kindling, in a neuroplasticity/pathology continuum of events. In particular, we suggest that neurotransmitter receptor regulation may be a key element leading to synaptic modification: in the adult nervous system, homeostatic receptor regulation normally compensates for alterations in synaptic input, while in the developing nervous system a form of 'homeodynamic' receptor regulation prevails. Our model proposes that homeodynamic receptor regulation leading to an LTP-like effect triggers, or acts in concert with, synaptogenesis to allow young neurons to modify response characteristics in response to altered input. In contrast, some forms of LTP in adult neurons may represent a 'failed' form of receptor regulation whose final outcome is neural death. The model suggests a series of experimentally verifiable hypotheses.
Collapse
Affiliation(s)
- J C McEachern
- Department of Physiology, University of British Columbia, Vancouver, Canada
| | | |
Collapse
|
47
|
Abstract
The present report demonstrates that glutathione (GSH), a tripeptide composed of glutamate, glycine and cysteine (gamma-L-glutamyl-L-cysteinyl-glycine) and best known as a free radical scavenger, elicits a large fast depolarizing potential when applied to cortical slices. This potential is maximally larger than that produced by either NMDA or AMPA. Like AMPA, the GSH current appears to be carried by sodium ions, but cannot be blocked by the glutamate receptor antagonists AP5 or DNQX. In addition, removal of external calcium or blockade of potassium currents by TEA does not diminish the GSH-induced potential. Together, these results suggest that GSH acts through its own receptor-mediated channels, independently of the known EAA receptors, and that its receptors may be a key, and previously unknown, component of cortical excitatory neurotransmission.
Collapse
Affiliation(s)
- C A Shaw
- Department of Ophthalmology, University of British Columbia, Vancouver, Canada
| | | | | |
Collapse
|
48
|
Abstract
The neurodegenerative disease, amyotrophic lateral sclerosis (ALS), is characterized by the selective death of motoneurones and corticospinal tract neurones. Abnormalities in excitatory amino acids and their receptors, as well as disordered function of voltage-dependent Ca2+ channels and superoxide dismutase have been reported in ALS patients. Furthermore, the activity of protein kinase C (PKC), a Ca2+, phospholipid-dependent enzyme, is also substantially increased in tissue from ALS patients, suggesting that alterations in intracellular free Ca2+ may be central to many of the diverse pathogenic mechanisms potentially responsible for ALS as discussed here by Charles Krieger and colleagues. Increased PKC activity, in turn, may have direct or indirect effects on neuronal viability and influence the pathogenic process in ALS by modifying the phosphorylation of voltage-dependent Ca2+ channels, neurotransmitter receptors and structural proteins.
Collapse
Affiliation(s)
- C Krieger
- Department of Medicine, University of British Columbia, Vancouver, Canada
| | | | | | | |
Collapse
|
49
|
Lanius RA, Paddon HB, Mezei M, Wagey R, Krieger C, Pelech SL, Shaw CA. A role for amplified protein kinase C activity in the pathogenesis of amyotrophic lateral sclerosis. J Neurochem 1995; 65:927-30. [PMID: 7616256 DOI: 10.1046/j.1471-4159.1995.65020927.x] [Citation(s) in RCA: 27] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Abstract
Amyotrophic lateral sclerosis (ALS) is a human neurodegenerative disorder of unknown origin that is characterized by progressive degeneration of corticospinal tracts and anterior horn cells in the brainstem and spinal cord. Previous studies have indicated that motoneuron degeneration associated with ALS may be triggered by mechanisms leading to increased intracellular Ca2+. In the present report, Ca(2+)-activated phospholipid-dependent protein kinase C (PKC) was evaluated in cervical spinal cords from ALS patients and control subjects. In patients who died with ALS, PKC histone H1 phosphotransferase activity was significantly increased by 330% in cytosolic- and 118% in particulate-derived extracts compared with controls. This increase in PKC phosphotransferase activity appeared to be partially due to an increase in the amount of PKC protein present in ALS spinal cord tissue. PKC histone H1 phosphotransferase activities of cytosolic- and particulate-derived extracts from motor and visual cortex of ALS patients and controls were not statistically different, nor were there differences in PKC histone H1 phosphotransferase activity in platelets and leukocytes. The specific nature of PKC alterations in affected regions of the CNS supports a role for PKC in the events leading to motoneuron death in sporadic ALS.
Collapse
Affiliation(s)
- R A Lanius
- Neuroscience Programme, University of British Columbia, Vancouver, Canada
| | | | | | | | | | | | | |
Collapse
|
50
|
Abstract
What is neuroplasticity and what are its origins? These questions have been the subject of intense theoretical and experimental research in the neurosciences for decades. Basically, the term neuroplasticity refers to the ability of neurons to alter some functional property in response to alterations in input. Traditional definitions, however, are often imprecise and restricted to particular 'model' neural systems. In the present article we will consider several of the most widely studied models of synaptic-level neuroplasticity including alterations in response properties of two types of invertebrate sensory neurons, long-term potentiation (LTP) in mammalian hippocampus and cortex, and ocular dominance shifts in cat visual cortex. While many other forms of neuroplasticity have been studied, these examples typify the diversity of the subject, as well as illustrate our contention that no unitary model of the phenomena is possible for all conditions. This last point is of particular importance for the mammalian literature, since many hypotheses concerning the mechanism(s) underlying the initiation of neuroplasticity have proposed a single crucial molecular element as the primary causal agent. A closer examination of these various hypotheses, in concert to several examples from the invertebrate literature, leads, however, to the conclusion that synaptic neuroplasticity must arise from a series of inter-related molecular events of a particular form, a cascade, in which individual elements may differ radically from system to system. We next provide an overview of our studies of age-dependent regulation of excitatory and inhibitory ionotropic neurotransmitter receptor populations in cortex in response to agonist and depolarizing stimulation. We provide evidence that such regulation for ionotropic receptors is under the control of ionically driven receptor kinase and phosphatase activity which is also age-dependent in function. These data provide the basis for a cascade model of receptor regulation. Based on this qualitative model, we describe a quantitative computer simulation of certain age-dependent stages in the receptor regulatory cascade which may interact to produce LTP-like effects. While such a model is not exclusive, it nevertheless provides a demonstration that elements in the proposed cascade may comprise the necessary and sufficient conditions for some forms of neuroplasticity. We also propose some of the principles underlying our model as a means of unifying much of the diverse phenomenology reported in the literature. Finally, we make a series of explicit predictions which are testable with current experimental techniques.(ABSTRACT TRUNCATED AT 250 WORDS)
Collapse
Affiliation(s)
- C A Shaw
- Department of Ophthalmology, University of British Columbia, Vancouver, Canada
| | | | | |
Collapse
|